Article
Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.
PloS one - 1 Jan 2012
van der Waart Anniek B, van der Velden Walter J F M, van Halteren Astrid G S, Leenders Marij J L G, Feuth Ton, Blijlevens Nicole M A, van der Voort Robbert, Dolstra Harry
Abstract excerpt
The C-type lectin-like receptor CD161 is a well-established marker for human IL17-producing T cells, which have been implicated to contribute to the development of graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (allo-SCT). In this study, we analyzed CD161(+) T cell re...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
